API | rabies vaccine (purified chick embryo cell vaccine)

rabies vaccine (purified chick embryo cell vaccine) (RabAvert) Report issue

Vaccine Approved ^FDA

AACT ChEMBL

Active Ingredient History

NOW

The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for a period of time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
rabies vaccine

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

imovax rabies | rabavert | rabies vaccine

Organizations (32)

Research & Development (32)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (14)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (14)

Allergy and Immunology (Phase 4)

Drugs, Investigational (Phase 4)

Encephalitis, Japanese (Phase 2)

Healthy Volunteers (Phase 3)

HIV Infections (Phase 2)

Malaria (Phase 3)

Malaria, Falciparum (Phase 1)

Pharmacological and Toxicological Phenomena (Phase 3)

Pre-Exposure Prophylaxis (Phase 2)

Rabies (Phase 4)

Rabies virus (Phase 3)

Streptococcal Infections (Phase 1/Phase 2)

Virus Diseases (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 42
# of Trial Organizations: 32

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue